rifapentine 150 MG Oral Tablet [Priftin]

RxCUI
261101
RxNorm name
rifapentine 150 MG Oral Tablet [Priftin]
Display name
rifapentine 150 MG Oral Tablet [Priftin]
Full name
rifapentine 150 MG Oral Tablet [Priftin]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PriftinRIFAPENTINEsanofi-aventis U.S. LLC3a64fb70-b85e-43d9-8bcd-7e893f568ae12026-02-06Warnings, Adverse reactionsExact identifier
rxcui: 261101

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3a64fb70-b85e-43d9-8bcd-7e893f568ae1Priftin 150 MG Oral Tablet [PSN] · rifapentine 150 MG Oral Tablet [Priftin] [SBD] · Priftin 150 MG Oral Tablet [SY]314These highlights do not include all the information needed to use PRIFTIN ® safely and effectively. See full prescribing information for PRIFTIN. PRIFTIN (rifapentine) tablets, for oral use Initial U.S. Approval: 199820260206
c3882444-18ca-4708-a51b-6c089664c10cPriftin 150 MG Oral Tablet [PSN] · rifapentine 150 MG Oral Tablet [Priftin] [SBD] · Priftin 150 MG Oral Tablet [SY]32These highlights do not include all the information needed to use PRIFTIN ® safely and effectively. See full prescribing information for PRIFTIN. PRIFTIN (rifapentine) tablets, for oral use Initial U.S. Approval: 199820230606